| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/24/2001 | US6265199 Amino acid sequence of polypeptide which is modulator of cell-cell interaction; for therapy and drug delivery |
| 07/24/2001 | US6265198 Parasite astacin metalloendopeptidase proteins |
| 07/24/2001 | US6265197 Starch debranching enzymes |
| 07/24/2001 | US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma |
| 07/24/2001 | US6265194 Dna encoding a polypeptide of defined amino acid sequence; antiproliferative agents; antitumor agents; antipyretics; antiinflammatory agents; immunosuppressants |
| 07/24/2001 | US6265193 DNA polymerases having improved labeled nucleotide incorporation properties |
| 07/24/2001 | US6265192 Glycosly sulfortransferase-3 |
| 07/24/2001 | US6265191 Immobilization of pseudomonas lipase on surfaces for oil removal |
| 07/24/2001 | US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection |
| 07/24/2001 | US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins |
| 07/24/2001 | US6265177 Enzyme assay for mutant firefly luciferase |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264945 Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 07/24/2001 | US6264925 Prevention, removal dental plaque |
| 07/24/2001 | CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin |
| 07/24/2001 | CA2037291C Dna fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant |
| 07/19/2001 | WO2001051651A2 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 07/19/2001 | WO2001051647A2 Method for increasing the content of fatty acids in plants and micro-organisms |
| 07/19/2001 | WO2001051643A1 Mutant apre promoter |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051640A2 Regulation of human mitochondrial transformylase |
| 07/19/2001 | WO2001051639A2 Everninomicin biosynthetic genes |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051629A2 Circularly permutated, interaction-activated proteins |
| 07/19/2001 | WO2001051624A2 Carboxypeptidase b free of animal products and contaminating enyzme activity |
| 07/19/2001 | WO2001051623A1 Cod uracil-dna glycosylase, gene coding therefore, recombinant dna containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling pcr |
| 07/19/2001 | WO2001051622A2 P450 monooxygenases of the cyp79 family |
| 07/19/2001 | WO2001051621A2 Dna polymerase mutant having one or more mutations in the active site |
| 07/19/2001 | WO2001051620A2 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 07/19/2001 | WO2001051524A1 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001050847A2 Reca / rad51 recombinase-mediated production of recombinant organisms |
| 07/19/2001 | WO2001050829A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/19/2001 | WO2001005811A3 Cyclic peptidomimetic urokinase receptor antagonists |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004331A3 Enhanced expression of proteins using gfp |
| 07/19/2001 | WO2001002424A3 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000071703A3 Inhibition of histone deacetylase |
| 07/19/2001 | WO2000065053A3 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
| 07/19/2001 | WO2000065040A3 Cell cycle genes from plants and methods of use |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | US20010009040 Introducing expression cassette comprising coding for fumonisin esterase enzyme and identifying transformed/ surviving plant cells |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008934 Stablity; useful in drugs, vaccines, personal care/cosmetics, veterinary drugs/vaccines, foods, feeds, diagnostics, cleaning agents (detergents and decontaminants); catalytic and binding components of biosensors |
| 07/19/2001 | DE19960703A1 Verfahren zur kontinuierlichen Kultivierung von Mikroorganismen der Gattung Eremothecium Process for the continuous cultivation of microorganisms of the genus Eremothecium |
| 07/19/2001 | DE19960206A1 Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung Complexation of RNA with polyethyleneimine for their stabilization and cellular infiltration |
| 07/19/2001 | DE10001101A1 Neue für das ptsH-Gen codierende Nukleotidsequenzen New coding for the ptsH gene nucleotide sequences |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2399626A1 Method for increasing the content of fatty acids in plants and micro-organisms |
| 07/19/2001 | CA2399366A1 Reca / rad51 recombinase-mediated production of recombinant organisms |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397162A1 Circularly permutated, interaction-activated proteins |
| 07/19/2001 | CA2396375A1 P450 monooxygenases of the cyp79 family |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1116795A1 Process for producing optically active pyridineethanol derivatives |
| 07/18/2001 | EP1116794A2 Transgenic plants carrying neoxanthin cleavage enzyme gene |
| 07/18/2001 | EP1116789A1 A method for synthesizing an optically active cyanohydrin |
| 07/18/2001 | EP1116028A1 Ndp |
| 07/18/2001 | EP1115886A2 Secreted renilla luciferase |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115873A1 Orange fruit pectinacetylesterase |
| 07/18/2001 | EP1115871A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 07/18/2001 | EP1115856A1 Method for making insertional mutations |
| 07/18/2001 | EP1115855A1 RESPONSE REGULATOR CaSSK1 |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115848A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115846A1 Rec2 kinase |
| 07/18/2001 | EP1115845A2 Fibrils |
| 07/18/2001 | EP1115844A2 Sequenzes of putative plant acyltransferases |
| 07/18/2001 | EP1115843A1 Method for preparing a mixture of starch branching enzymes extracted from algae |
| 07/18/2001 | EP1115828A1 Laundry detergent and/or fabric care compositions comprising a chemical entity which contains a deposition aid with a high affinity for cellulose, a surfactant and a protease |
| 07/18/2001 | EP1115741A2 Stereoselective process for enalapril |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115366A2 Personal care compositions containing active proteins tethered to a water insoluble substrate |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1303946A Novel human ATP synthase and its code sequence |
| 07/18/2001 | CN1303945A Novel polypeptide-serine/threonine kinase 39 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303944A Novel polypeptide-threonine synthetase 71 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303943A Novel polypeptide-CoA carboxylase 41 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303928A Complex of cytochrome c oxidase |
| 07/18/2001 | CN1303927A Novel polypeptide-steroid dehydrogenase 34 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303926A Novel polypeptide-NADH-cytochrome B5 reductase 33 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303925A Novel polypeptide-arginyl tRNA synthetase 44 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303921A Continuous ferment process |
| 07/18/2001 | CN1303677A Activator and inhibitor of profibrinolysin and agent of external use for skin for mating it |
| 07/18/2001 | CN1068629C Ethanol production by recombinant hosts |
| 07/18/2001 | CN1068503C Hydrolytic process of mannogalactan in liquid coffee extract |
| 07/17/2001 | US6262346 Modifying ethylene biosynthesis in plant via inserting into its genome a dna sequence in sense or antisense configuration which encodes for 1-aminocylcopropane-1-carboxylic acid synthase (acs) or an ethylene-forming enzyme (efe) |